Investment Criteria

Cyprium Partners seeks to invest common equity, preferred stock, or less-dilutive subordinated debt in companies that have a compelling business model, a carefully conceived vision for long-term growth, and meet the following criteria:

• Manufacturing, distribution, healthcare or business services, including technology-enabled companies
• Sales between $40 million and $500 million
• Minimum historical EBITDA of $8 million
• Investment size of $10 million to $60 million
• History of growth and profitable operations
• Shareholders interested in collaborating with an informed investor
• Headquartered in the United States or Canada

Transaction Types:

• Acquisition financing
• Growth capital
• Shareholder or partner buy–out
• Shareholder dividends for wealth diversification
• Debt refinancing
• Management buy–out (MBO) and buy–in (MBI)
• Transfer of business ownership to other family members
• ESOP transactions

Generally, we do not invest in operational turnaround situations or imperiled companies, and we avoid investments in financial services, real estate, commodities, restaurants, long-term care, and healthcare companies with significant government reimbursement risk.